Kaori Ochiai

Statistics

Publications

Citations

150

H-Index

Active since

2007

Affiliations

Boehringer Ingelheim (Japan)(Current)

Nippon Medical School

Kaori Ochiai is an author at Boehringer Ingelheim (Japan) specializing in post-marketing surveillance, post-marketing surveillance data, and pharmacology.

Publications per year

2007–2023

Publications

Restoration of innate host defense responses by oral supplementation of branched‐chain amino acids in decompensated cirrhotic patients

Ikuo Nakamura, Kaori Ochiai, Yasuharu Imai et al. · Hepatology Research · 2007 · 46 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan

Takashi Ogura, Yoshikazu Inoue, Arata Azuma et al. · Advances in Therapy · 2023 · 38 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study

Kohei Kaku, Rina Chin, Yusuke Naito et al. · Expert Opinion on Drug Safety · 2019 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study

Masahiro Yasaka, Hiroyuki Yokota, Michiyasu Suzuki et al. · Cardiology and Therapy · 2020 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of whole-body neuromuscular electrical stimulation device on hemodynamics, arrhythmia, and sublingual microcirculation

Megumi Hoshiai, Kaori Ochiai, Yuma Tamura et al. · Heart and Vessels · 2021 · 11 citations · Full text

Medicine, Physiology, Rehabilitation Medicine +16

1–5 of 6